{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T22:55:48Z","timestamp":1795128948221,"version":"4.10.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400213"],"award-info":[{"award-number":["82400213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02392-w","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T03:34:21Z","timestamp":1753241661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Metabolic reprogramming promotes apoptosis resistance in acute lymphoblastic leukemia through CASP3 lactylation"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhi","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Klionsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daolin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"2392_CR1","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/s0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet (London England). 2020;395:1146\u201362. https:\/\/doi.org\/10.1016\/s0140-6736(19)33018-1.","journal-title":"Lancet (London England)"},{"key":"2392_CR2","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/s0140-6736(22)01541-0","volume":"400","author":"X Ni","year":"2022","unstructured":"Ni X, et al. Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in china: a cross-sectional study. Lancet (London England). 2022;400:1020\u201332. https:\/\/doi.org\/10.1016\/s0140-6736(22)01541-0.","journal-title":"Lancet (London England)"},{"key":"2392_CR3","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/s1470-2045(21)00328-4","volume":"22","author":"W Yang","year":"2021","unstructured":"Yang W, et al. Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial. Lancet Oncol. 2021;22:1322\u201332. https:\/\/doi.org\/10.1016\/s1470-2045(21)00328-4.","journal-title":"Lancet Oncol"},{"key":"2392_CR4","doi-asserted-by":"publisher","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Sci (New York N Y). 2020;368. https:\/\/doi.org\/10.1126\/science.aaw5473.","DOI":"10.1126\/science.aaw5473"},{"key":"2392_CR5","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","volume":"187","author":"SM Fendt","year":"2024","unstructured":"Fendt SM. 100 years of the Warburg effect: A cancer metabolism endeavor. Cell. 2024;187:3824\u20138. https:\/\/doi.org\/10.1016\/j.cell.2024.06.026.","journal-title":"Cell"},{"key":"2392_CR6","doi-asserted-by":"publisher","unstructured":"Fu Y et al. Lipid metabolism in cancer progression and therapeutic strategies. MedComm (2020) 2, 27\u201359 (2021). https:\/\/doi.org\/10.1002\/mco2.27","DOI":"10.1002\/mco2.27"},{"key":"2392_CR7","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cell.2014.07.048","volume":"158","author":"YH Wang","year":"2014","unstructured":"Wang YH, et al. Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis. Cell. 2014;158:1309\u201323. https:\/\/doi.org\/10.1016\/j.cell.2014.07.048.","journal-title":"Cell"},{"key":"2392_CR8","first-page":"168","volume":"65","author":"H Tian","year":"2007","unstructured":"Tian H, Cronstein BN. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull NYU Hosp Joint Dis. 2007;65:168\u201373.","journal-title":"Bull NYU Hosp Joint Dis"},{"key":"2392_CR9","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/sj.leu.2400834","volume":"11","author":"T Ueno","year":"1997","unstructured":"Ueno T, et al. Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase. Leukemia. 1997;11:1858\u201361. https:\/\/doi.org\/10.1038\/sj.leu.2400834.","journal-title":"Leukemia"},{"key":"2392_CR10","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41418-023-01153-w","volume":"30","author":"I Vitale","year":"2023","unstructured":"Vitale I, et al. Apoptotic cell death in disease-Current Understanding of the NCCD 2023. Cell Death Differ. 2023;30:1097\u2013154. https:\/\/doi.org\/10.1038\/s41418-023-01153-w.","journal-title":"Cell Death Differ"},{"key":"2392_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/15548627.2023.2259732","volume":"20","author":"Z Lin","year":"2024","unstructured":"Lin Z, et al. The lipid basis of cell death and autophagy. Autophagy. 2024;20:469\u201388. https:\/\/doi.org\/10.1080\/15548627.2023.2259732.","journal-title":"Autophagy"},{"key":"2392_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41375-022-01755-2","volume":"37","author":"VY Ling","year":"2023","unstructured":"Ling VY, et al. Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia. Leukemia. 2023;37:143\u201353. https:\/\/doi.org\/10.1038\/s41375-022-01755-2.","journal-title":"Leukemia"},{"key":"2392_CR13","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/s41375-022-01558-5","volume":"36","author":"K Bodaar","year":"2022","unstructured":"Bodaar K, et al. JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia. Leukemia. 2022;36:1499\u2013507. https:\/\/doi.org\/10.1038\/s41375-022-01558-5.","journal-title":"Leukemia"},{"key":"2392_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ccr.2006.10.006","volume":"10","author":"M Konopleva","year":"2006","unstructured":"Konopleva M, et al. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell. 2006;10:375\u201388. https:\/\/doi.org\/10.1016\/j.ccr.2006.10.006.","journal-title":"Cancer Cell"},{"key":"2392_CR15","first-page":"1242","volume":"63","author":"AD Schimmer","year":"2003","unstructured":"Schimmer AD, et al. Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy. Cancer Res. 2003;63:1242\u20138.","journal-title":"Cancer Res"},{"key":"2392_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41375-022-01800-0","volume":"37","author":"Z Aid","year":"2023","unstructured":"Aid Z, et al. High caspase 3 and vulnerability to dual BCL2 family Inhibition define ETO2::GLIS2 pediatric leukemia. Leukemia. 2023;37:571\u20139. https:\/\/doi.org\/10.1038\/s41375-022-01800-0.","journal-title":"Leukemia"},{"key":"2392_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41418-024-01284-8","volume":"31","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, et al. Diverse functions of cytochrome c in cell death and disease. Cell Death Differ. 2024;31:387\u2013404. https:\/\/doi.org\/10.1038\/s41418-024-01284-8.","journal-title":"Cell Death Differ"},{"key":"2392_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"PE Czabotar","year":"2014","unstructured":"Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014;15:49\u201363. https:\/\/doi.org\/10.1038\/nrm3722.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2392_CR19","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1007\/s12094-022-03070-9","volume":"25","author":"I Ploumaki","year":"2023","unstructured":"Ploumaki I, et al. Bcl-2 pathway Inhibition in solid tumors: a review of clinical trials. Clin Transl Oncol. 2023;25:1554\u201378. https:\/\/doi.org\/10.1007\/s12094-022-03070-9.","journal-title":"Clin Transl Oncol"},{"key":"2392_CR20","doi-asserted-by":"publisher","first-page":"101195","DOI":"10.1016\/j.blre.2024.101195","volume":"65","author":"DJ Fowler-Shorten","year":"2024","unstructured":"Fowler-Shorten DJ, Hellmich C, Markham M, Bowles KM, Rushworth SA. BCL-2 Inhibition in haematological malignancies: clinical application and complications. Blood Rev. 2024;65:101195. https:\/\/doi.org\/10.1016\/j.blre.2024.101195.","journal-title":"Blood Rev"},{"key":"2392_CR21","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1056\/NEJMoa1713976","volume":"378","author":"JF Seymour","year":"2018","unstructured":"Seymour JF, et al. Venetoclax-Rituximab in relapsed or refractory chronic lymphocytic leukemia. N Engl J Med. 2018;378:1107\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1713976.","journal-title":"N Engl J Med"},{"key":"2392_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood.2023022481","volume":"143","author":"F Thol","year":"2024","unstructured":"Thol F, D\u00f6hner H, Ganser A. How I treat refractory and relapsed acute myeloid leukemia. Blood. 2024;143:11\u201320. https:\/\/doi.org\/10.1182\/blood.2023022481.","journal-title":"Blood"},{"key":"2392_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbrc.2021.05.049","volume":"562","author":"S Zhu","year":"2021","unstructured":"Zhu S, Liu J, Kang R, Yang M, Tang D. Targeting NF-kappaB-dependent alkaliptosis for the treatment of venetoclax-resistant acute myeloid leukemia cells. Biochem Biophys Res Commun. 2021;562:55\u201361. https:\/\/doi.org\/10.1016\/j.bbrc.2021.05.049.","journal-title":"Biochem Biophys Res Commun"},{"key":"2392_CR24","doi-asserted-by":"publisher","unstructured":"Sharma A, Boise LH, Shanmugam M. Cancer metabolism and the evasion of apoptotic cell death. Cancers (Basel). 2019;11. https:\/\/doi.org\/10.3390\/cancers11081144.","DOI":"10.3390\/cancers11081144"},{"key":"2392_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/jamaoncol.2019.5868","volume":"6","author":"S Shen","year":"2020","unstructured":"Shen S, et al. Effect of dasatinib vs Imatinib in the treatment of pediatric Philadelphia Chromosome-Positive acute lymphoblastic leukemia: A randomized clinical trial. JAMA Oncol. 2020;6:358\u201366. https:\/\/doi.org\/10.1001\/jamaoncol.2019.5868.","journal-title":"JAMA Oncol"},{"key":"2392_CR26","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1182\/blood.V87.10.4325.bloodjournal87104325","volume":"87","author":"F Arguello","year":"1996","unstructured":"Arguello F, et al. Two serologic markers to monitor the engraftment, growth, and treatment response of human leukemias in severe combined immunodeficient mice. Blood. 1996;87:4325\u201332.","journal-title":"Blood"},{"key":"2392_CR27","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/198586a0","volume":"198","author":"JL Nussbaum","year":"1963","unstructured":"Nussbaum JL, Bieth R, Mandel P. Phosphatides in Myelin sheaths and repartition of sphingomyelin in the brain. Nature. 1963;198:586\u20137. https:\/\/doi.org\/10.1038\/198586a0.","journal-title":"Nature"},{"key":"2392_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.emboj.7600034","volume":"23","author":"K Huitema","year":"2004","unstructured":"Huitema K, van den Dikkenberg J, Brouwers JF, Holthuis JC. Identification of a family of animal sphingomyelin synthases. EMBO J. 2004;23:33\u201344. https:\/\/doi.org\/10.1038\/sj.emboj.7600034.","journal-title":"EMBO J"},{"key":"2392_CR29","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/0092-8674(94)90275-5","volume":"78","author":"K Wiegmann","year":"1994","unstructured":"Wiegmann K, Sch\u00fctze S, Machleidt T, Witte D, Kr\u00f6nke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell. 1994;78:1005\u201315. https:\/\/doi.org\/10.1016\/0092-8674(94)90275-5.","journal-title":"Cell"},{"key":"2392_CR30","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/advances\/nmab117","volume":"13","author":"C Jiang","year":"2022","unstructured":"Jiang C, et al. Dietary sphingomyelin metabolism and roles in gut health and cognitive development. Adv Nutr (Bethesda Md). 2022;13:474\u201391. https:\/\/doi.org\/10.1093\/advances\/nmab117.","journal-title":"Adv Nutr (Bethesda Md)"},{"key":"2392_CR31","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1021\/jf200943n","volume":"59","author":"N Blaas","year":"2011","unstructured":"Blaas N, Sch\u00fc\u00fcrmann C, Bartke N, Stahl B, Humpf HU. Structural profiling and quantification of sphingomyelin in human breast milk by HPLC-MS\/MS. J Agric Food Chem. 2011;59:6018\u201324. https:\/\/doi.org\/10.1021\/jf200943n.","journal-title":"J Agric Food Chem"},{"key":"2392_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1194\/jlr.M600344-JLR200","volume":"48","author":"M Valsecchi","year":"2007","unstructured":"Valsecchi M, et al. Ceramide and sphingomyelin species of fibroblasts and neurons in culture. J Lipid Res. 2007;48:417\u201324. https:\/\/doi.org\/10.1194\/jlr.M600344-JLR200.","journal-title":"J Lipid Res"},{"key":"2392_CR33","doi-asserted-by":"publisher","first-page":"36053","DOI":"10.1074\/jbc.M111.228593","volume":"286","author":"ABA Shakor","year":"2011","unstructured":"Shakor ABA, et al. Sphingomyelin synthase 1-generated sphingomyelin plays an important role in transferrin trafficking and cell proliferation. J Biol Chem. 2011;286:36053\u201362. https:\/\/doi.org\/10.1074\/jbc.M111.228593.","journal-title":"J Biol Chem"},{"key":"2392_CR34","doi-asserted-by":"publisher","first-page":"e1470","DOI":"10.1038\/cddis.2014.431","volume":"5","author":"T Liu","year":"2014","unstructured":"Liu T, et al. Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis. Cell Death Dis. 2014;5:e1470. https:\/\/doi.org\/10.1038\/cddis.2014.431.","journal-title":"Cell Death Dis"},{"key":"2392_CR35","doi-asserted-by":"publisher","unstructured":"Pan L, et al. PON2 subverts metabolic gatekeeper functions in B cells to promote leukemogenesis. Proc Natl Acad Sci USA. 2021;118. https:\/\/doi.org\/10.1073\/pnas.2016553118.","DOI":"10.1073\/pnas.2016553118"},{"key":"2392_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41577-019-0154-3","volume":"19","author":"M M\u00fcschen","year":"2019","unstructured":"M\u00fcschen M. Metabolic gatekeepers to safeguard against autoimmunity and oncogenic B cell transformation. Nat Rev Immunol. 2019;19:337\u201348. https:\/\/doi.org\/10.1038\/s41577-019-0154-3.","journal-title":"Nat Rev Immunol"},{"key":"2392_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature24057","volume":"551","author":"S Hui","year":"2017","unstructured":"Hui S, et al. Glucose feeds the TCA cycle via Circulating lactate. Nature. 2017;551:115\u20138. https:\/\/doi.org\/10.1038\/nature24057.","journal-title":"Nature"},{"key":"2392_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.06.017","author":"W Liu","year":"2023","unstructured":"Liu W, et al. Lactate modulates iron metabolism by binding soluble adenylyl cyclase. Cell Metabol. 2023. https:\/\/doi.org\/10.1016\/j.cmet.2023.06.017.","journal-title":"Cell Metabol"},{"key":"2392_CR39","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.molcel.2015.04.015","volume":"58","author":"EE Lee","year":"2015","unstructured":"Lee EE, et al. A protein kinase C phosphorylation motif in GLUT1 affects glucose transport and is mutated in GLUT1 deficiency syndrome. Mol Cell. 2015;58:845\u201353. https:\/\/doi.org\/10.1016\/j.molcel.2015.04.015.","journal-title":"Mol Cell"},{"key":"2392_CR40","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1038\/s41467-018-03914-5","volume":"9","author":"L Zhou","year":"2018","unstructured":"Zhou L, et al. HOXA9 inhibits HIF-1\u03b1-mediated Glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development. Nat Commun. 2018;9:1480. https:\/\/doi.org\/10.1038\/s41467-018-03914-5.","journal-title":"Nat Commun"},{"key":"2392_CR41","doi-asserted-by":"publisher","first-page":"19345","DOI":"10.1073\/pnas.0709747104","volume":"104","author":"RJ DeBerardinis","year":"2007","unstructured":"DeBerardinis RJ, et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA. 2007;104:19345\u201350. https:\/\/doi.org\/10.1073\/pnas.0709747104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2392_CR42","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17:395\u2013417. https:\/\/doi.org\/10.1038\/s41571-020-0341-y.","journal-title":"Nat Rev Clin Oncol"},{"key":"2392_CR43","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1182\/blood-2018-02-791350","volume":"132","author":"R Valentin","year":"2018","unstructured":"Valentin R, Grabow S, Davids MS. The rise of apoptosis: targeting apoptosis in hematologic malignancies. Blood. 2018;132:1248\u201364. https:\/\/doi.org\/10.1182\/blood-2018-02-791350.","journal-title":"Blood"},{"key":"2392_CR44","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009967","author":"M Rodriguez-Zabala","year":"2023","unstructured":"Rodriguez-Zabala M, et al. Combined GLUT1 and OXPHOS Inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity. Blood Adv. 2023. https:\/\/doi.org\/10.1182\/bloodadvances.2023009967.","journal-title":"Blood Adv"},{"key":"2392_CR45","doi-asserted-by":"publisher","unstructured":"Chen Z et al. Peptide-appended Nanosonosensitizers Targeting Tumor Glycolysis for Synergistic Sonodynamic-Immunometabolic Therapy of Spinal-Metastasized Tumor. Advanced materials (Deerfield Beach, Fla.), e2304246 (2023). https:\/\/doi.org\/10.1002\/adma.202304246","DOI":"10.1002\/adma.202304246"},{"key":"2392_CR46","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380. https:\/\/doi.org\/10.1038\/s41586-019-1678-1.","journal-title":"Nature"},{"key":"2392_CR47","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"Chen H, et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature. 2024;631:663\u20139. https:\/\/doi.org\/10.1038\/s41586-024-07620-9.","journal-title":"Nature"},{"key":"2392_CR48","doi-asserted-by":"publisher","unstructured":"Reed JC, Doctor KS, Godzik A. The domains of apoptosis: a genomics perspective. Science\u2019s STKE: signal Transduct Knowl Environ. 2004;2004(re9). https:\/\/doi.org\/10.1126\/stke.2392004re9.","DOI":"10.1126\/stke.2392004re9"},{"key":"2392_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2024.05.016","author":"J Zhou","year":"2024","unstructured":"Zhou J, et al. Astrocytic LRP1 enables mitochondria transfer to neurons and mitigates brain ischemic stroke by suppressing ARF1 lactylation. Cell Metabol. 2024. https:\/\/doi.org\/10.1016\/j.cmet.2024.05.016.","journal-title":"Cell Metabol"},{"key":"2392_CR50","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1097\/hep.0000000000000279","volume":"78","author":"R Gao","year":"2023","unstructured":"Gao R, et al. Mitochondrial pyruvate carrier 1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease. Hepatology (Baltimore MD). 2023;78:1800\u201315. https:\/\/doi.org\/10.1097\/hep.0000000000000279.","journal-title":"Hepatology (Baltimore MD)"},{"key":"2392_CR51","doi-asserted-by":"publisher","first-page":"7965","DOI":"10.1038\/s41467-022-35707-2","volume":"13","author":"Z Lin","year":"2022","unstructured":"Lin Z, et al. The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis. Nat Commun. 2022;13:7965. https:\/\/doi.org\/10.1038\/s41467-022-35707-2.","journal-title":"Nat Commun"},{"key":"2392_CR52","doi-asserted-by":"publisher","first-page":"18688","DOI":"10.1074\/jbc.M401205200","volume":"279","author":"S Yamaoka","year":"2004","unstructured":"Yamaoka S, Miyaji M, Kitano T, Umehara H, Okazaki T. Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells. J Biol Chem. 2004;279:18688\u201393. https:\/\/doi.org\/10.1074\/jbc.M401205200.","journal-title":"J Biol Chem"},{"key":"2392_CR53","doi-asserted-by":"publisher","unstructured":"Nagy N. Establishment of EBV-Infected lymphoblastoid cell lines. Methods in molecular biology. (Clifton N J). 2017;1532:57\u201364. https:\/\/doi.org\/10.1007\/978-1-4939-6655-4_3.","DOI":"10.1007\/978-1-4939-6655-4_3"},{"key":"2392_CR54","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.cmet.2024.01.013","volume":"36","author":"MJ Lu","year":"2024","unstructured":"Lu MJ, et al. SLC25A51 decouples the mitochondrial NAD(+)\/NADH ratio to control proliferation of AML cells. Cell Metabol. 2024;36:808\u2013e821806. https:\/\/doi.org\/10.1016\/j.cmet.2024.01.013.","journal-title":"Cell Metabol"},{"key":"2392_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2025.03.014","author":"X Song","year":"2025","unstructured":"Song X, et al. Cytosolic cytochrome c represses ferroptosis. Cell Metab. 2025. https:\/\/doi.org\/10.1016\/j.cmet.2025.03.014.","journal-title":"Cell Metab"},{"key":"2392_CR56","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.cmet.2024.01.017","volume":"36","author":"X Ji","year":"2024","unstructured":"Ji X, et al. Sphingolipid metabolism controls mammalian heart regeneration. Cell Metabol. 2024;36:839\u2013e856838. https:\/\/doi.org\/10.1016\/j.cmet.2024.01.017.","journal-title":"Cell Metabol"},{"key":"2392_CR57","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1038\/s41467-025-57583-2","volume":"16","author":"F Chen","year":"2025","unstructured":"Chen F, et al. CYP51A1 drives resistance to pH-dependent cell death in pancreatic cancer. Nat Commun. 2025;16:2278. https:\/\/doi.org\/10.1038\/s41467-025-57583-2.","journal-title":"Nat Commun"},{"key":"2392_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2024.07.018","author":"L Yan","year":"2024","unstructured":"Yan L, et al. Physical exercise mediates cortical synaptic protein lactylation to improve stress resilience. Cell Metabol. 2024. https:\/\/doi.org\/10.1016\/j.cmet.2024.07.018.","journal-title":"Cell Metabol"},{"key":"2392_CR59","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cmet.2023.04.018","volume":"35","author":"H Sun","year":"2023","unstructured":"Sun H, et al. Sustained remission of type 2 diabetes in rodents by centrally administered fibroblast growth factor 4. Cell Metabol. 2023;35:1022\u20131037.e1026 https:\/\/doi.org\/10.1016\/j.cmet.2023.04.018.","journal-title":"Cell Metabol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02392-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02392-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02392-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T05:52:38Z","timestamp":1770789158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-025-02392-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2392"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02392-w","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The published version was updated as the supplementary materials were out of order and some files were missing.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"G.K. has been holding research contracts with Daiichi Sankyo, Eleor, Kaleido, Lytix Pharma, PharmaMar, Osasuna Therapeutics, Samsara Therapeutics, Sanofi, Sutro, Tollys, and Vascage. GK is on the Board of Directors of the Bristol Myers Squibb Foundation France. GK is a scientific co-founder of everImmune, Osasuna Therapeutics, Samsara Therapeutics and Therafast Bio. GK is in the scientific advisory boards of Hevolution, Institut Servier, Longevity Vision Funds and Rejuveron Life Sciences. GK is the inventor of patents covering therapeutic targeting of aging, cancer, cystic fibrosis and metabolic disorders. Among these patents, one \u201cMethods for weight reduction\u201d (US11905330B1) is relevant to this study. GK\u2019s brother, Romano Kroemer, was an employee of Sanofi and now consults for Boehringer-Ingelheim. IM is a consultant of everImmune. GK\u2019s wife, Laurence Zitvogel, has held research contracts with Glaxo Smyth Kline, Incyte, Lytix, Kaleido, Innovate Pharma, Daiichi Sankyo, Pilege, Merus, Transgene, 9\u00a0m, Tusk and Roche, was on the on the Board of Directors of Transgene, is a cofounder of everImmune, and holds patents covering the treatment of cancer and the therapeutic manipulation of the microbiota. The funders had no role in the design of the study; in the writing of the manuscript, or in the decision to publish the results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}